Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes

Masaki Kato,Susumu Hamada-Tsutsumi,Chiaki Okuse,Aiko Sakai,Nobuyuki Matsumoto,Masaaki Sato,Toshiyuki Sato,Mitsumi Arito,Kazuki Omoteyama,Naoya Suematsu,Kazuki Okamoto,Takanobu Kato,Fumio Itoh,Ryo Sumazaki,Yasuhito Tanaka,Hiroshi Yotsuyanagi,Tomohiro Kato,Manae S. Kurokawa

Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes

2017

Masaki Kato
Susumu Hamada-Tsutsumi
Chiaki Okuse
Aiko Sakai
Nobuyuki Matsumoto
Masaaki Sato
Toshiyuki Sato
Mitsumi Arito
Kazuki Omoteyama
Naoya Suematsu
Kazuki Okamoto
Takanobu Kato
Fumio Itoh
Ryo Sumazaki
Yasuhito Tanaka
Hiroshi Yotsuyanagi
Tomohiro Kato
Manae S. Kurokawa

Background In universal hepatitis B (HB) vaccination, single vaccine-derived polyclonal anti-HBs antibodies (anti-HBs) need to inhibit infection of HB viruses (HBV) of non-vaccine genotypes. We experimentally addressed this issue.

Keywords:

Antibody
Hepatitis B
Vaccination
Polyclonal antibodies
Genotype
Hepatitis B virus
Virology
Immunology
Medicine
Hepatology
anti hbs
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations